Pulse Biosciences, Inc Common Stock (DE)
PLSE
PLSE: Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
moreShow PLSE Financials
Recent trades of PLSE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PLSE's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: High-voltage analog circuit pulser and pulse generator discharge circuit Aug. 15, 2023
-
Patent Title: High-voltage analog circuit pulser Jul. 11, 2023
-
Patent Title: Treatment instrument and high-voltage connectors for robotic surgical system May. 02, 2023
-
Patent Title: Treatment of tissue by the application of energy Feb. 28, 2023
-
Patent Title: Moving electrodes for the application of electrical therapy within a tissue Feb. 14, 2023
-
Patent Title: High-voltage catheters for sub-microsecond pulsing Feb. 07, 2023
-
Patent Title: Nanosecond pulsed power sources having multi-core transformers Sep. 27, 2022
-
Patent Title: Treatment of tissue by the application of energy Apr. 26, 2022
-
Patent Title: High voltage connectors and electrodes for pulse generators Feb. 22, 2022
-
Patent Title: Treatment tip with protected electrodes Nov. 09, 2021
-
Patent Title: High-voltage analog circuit pulser Jul. 06, 2021
-
Patent Title: Methods and devices for stimulating an immune response using nanosecond pulsed electric fields Jul. 06, 2021
-
Patent Title: Pulse generator with independent panel triggering Mar. 16, 2021
-
Patent Title: High-voltage analog circuit pulser and pulse generator discharge circuit Dec. 29, 2020
-
Patent Title: Treatment instrument and high-voltage connectors for robotic surgical system Dec. 08, 2020
-
Patent Title: Treatment of tissue by the application of energy Dec. 01, 2020
-
Patent Title: Methods and devices for stimulating an immune response using nanosecond pulsed electric fields Aug. 04, 2020
-
Patent Title: Nanoelectroablation control and vaccination Jun. 30, 2020
-
Patent Title: High-voltage analog circuit pulser with feedback control Feb. 04, 2020
-
Patent Title: High voltage connectors for pulse generators Jan. 28, 2020
-
Patent Title: Methods and devices for stimulating an immune response using nanosecond pulsed electric fields Aug. 27, 2019
-
Patent Title: Nanoelectroablation control and vaccination Jun. 04, 2019
-
Patent Title: Pulse applicator Apr. 09, 2019
-
Patent Title: Inoculation by applying nanosecond pulsed electric fields to a biopsy and reintroducing the treated biopsy to the subject Nov. 27, 2018
-
Patent Title: Marking tissue surfaces for treatment of lesions by electrical nanopulses Oct. 23, 2018
-
Patent Title: Nanoelectroablation control and vaccination Aug. 28, 2018
-
Patent Title: Electric pulse generators May. 01, 2018
-
Patent Title: Nanoelectroablation control and vaccination Aug. 08, 2017
-
Patent Title: Methods and devices for stimulating an immune response using nanosecond pulsed electric fields May. 23, 2017
-
Patent Title: In vivo treatment of skin lesions by electrical nanopulses May. 23, 2017
Federal grants, loans, and purchases
Followers on PLSE's company Twitter account
Number of mentions of PLSE in WallStreetBets Daily Discussion
Recent insights relating to PLSE
Recent picks made for PLSE stock on CNBC
ETFs with the largest estimated holdings in PLSE
Flights by private jets registered to PLSE